The China-based ophthalmology hospital group will provide 9.8% of the capital for the fund, which will target eyecare startups in the region.
China-based ophthalmology hospital group Aier Eye Hospital is set to establish a RMB 1bn ($160m) fund together with Tibet-based Dazi Zhongyu Health Venture Investment Fund, according to China Money Network.
Hunan Aier Zhongyu Ophthalmology Healthcare Industry Investment Fund will receive 9.8% of its capital from Aier, while Zhongyu will invest 0.2% of the capital and be responsible for raising the remaining 90% from third parties. The two will jointly act as fund manager.
The fund will focus on industry consolidation…
